Global POC Diagnostics Market 2015-2019

About POC Diagnostics
POC diagnostics are IVD devices and tools used for diagnosing diseases in patients outside a clinical laboratory setting. The use of these devices helps in the rapid diagnosis of the medical conditions and aids in providing appropriate treatments and medication to patients. They are cost-effective, user-friendly, and standardized to minimize errors during diagnosis. They are being used extensively for diagnostic purposes owing to the high prevalence of lifestyle diseases such as diabetes and obesity, cardiac disorders, and infectious diseases. They have a wide range of applications in clinical diagnosis such as the testing of blood glucose and coagulation, infectious diseases, cardiac markers, pregnancy and fertility, blood gas/electrolytes, tumor markers, urinalysis, and cholesterol.
TechNavio's analysts forecast the Global POC Diagnostics market to grow at a CAGR of 8.47 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global POC Diagnostics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of POC diagnostics used in various applications:
‧ Blood glucose testing
‧ Infectious diseases testing
‧ Cardiac markers testing
‧ Coagulation testing
‧ Pregnancy and fertility testing
‧ Blood gas/electrolytes testing
‧ Tumor markers testing
‧ Urinalysis testing
‧ Cholesterol testing
TechNavio's report, the Global POC Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global POC Diagnostics market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
‧ Americas
‧ APAC
‧ EMEA
Key Vendors
‧ Abbott Laboratories
‧ Alere
‧ Bayer Healthcare
‧ Danaher
‧ F. Hoffmann-La Roche
‧ Johnson & Johnson
Other Prominent Vendors

‧ A. Menarini Diagnostics
‧ Abaxis
‧ Acon
‧ BD
‧ Bio-Rad Laboratories
‧ Chembio Diagnostics
‧ Chongqing Haray International Business
‧ Clarity Diagnostics
‧ Clinical Innovations
‧ Contec Medical
‧ Eurotrol
‧ Fudakang Ind'l
‧ Helena Laboratories
‧ i-sens
‧ International Technidyne
‧ Medtronic
‧ Nipro Diagnostics
‧ Nova Biomedical
‧ OraSure Technologies
‧ Phamatech
‧ Quidel
‧ Radiometer Medical
‧ Randox Laboratories
‧ SA Scientific
‧ Sekisui Diagnostics
‧ Shenzhen Fitconn Technology
‧ Siemens Healthcare
‧ STAT Technologies
‧ Streck
‧ TaiDoc
‧ Trinity Biotech
‧ Urit Medical
Market Driver
‧ High Prevalence of Diabetes and Obesity
‧ For a full, detailed list, view our report
Market Challenge
‧ Limitation of POC Diagnostics
‧ For a full, detailed list, view our report
Market Trend
‧ Rapid Adoption of POC Diagnostic Tests
‧ For a full, detailed list, view our report
Key Questions Answered in this Report
‧ What will the market size be in 2019 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 POC Diagnostics Market in US
06.3.1 Market Size and Forecast
06.4 POC Diagnostics Market in Europe
06.4.1 Market Size and Forecast
06.5 Five Forces Analysis
07. Market Segmentation by Application
07.1 Global Blood Glucose Testing Market
07.1.1 Market Size and Forecast
07.2 Global Infectious Diseases Testing Market
07.2.1 Market Size and Forecast
07.3 Global Cardiac Markers Testing Market
07.3.1 Market Size and Forecast
07.4 Global Coagulation Testing Market
07.4.1 Market Size and Forecast
07.5 Global Pregnancy and Fertility Testing Market
07.5.1 Market Size and Forecast
07.6 Global Blood Gas/Electrolytes Testing Market
07.6.1 Market Size and Forecast
07.7 Global Tumor Markers Testing Market
07.7.1 Market Size and Forecast
07.8 Global Urinalysis Testing Market
07.8.1 Market Size and Forecast
07.9 Global Cholesterol Testing Market
07.9.1 Market Size and Forecast
08. Geographical Segmentation
08.1 POC Diagnostics Market in Americas
08.1.1 Market Size and Forecast
08.2 POC Diagnostics Market in EMEA Region
08.2.1 Market Size and Forecast
08.3 POC Diagnostics Market in APAC Region
08.3.1 Market Size and Forecast
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Vendor Analysis 2014
16.3 Other Prominent Vendors
17. Key Vendor Analysis
17.1 Abbott Laboratories
17.1.1 Key Facts
17.1.2 Business Overview
17.1.3 Business Segmentation by Revenue
17.1.4 Business Segmentation by Revenue 2011 and 2012
17.1.5 Geographical Segmentation by Revenue
17.1.6 Business Strategy
17.1.7 Key Information
17.1.8 SWOT Analysis
17.2 Alere
17.2.1 Key Facts
17.2.2 Business Overview
17.2.3 Business Segmentation by Revenue 2013
17.2.4 Business Segmentation by Revenue 2012 and 2013
17.2.5 Geographical Segmentation by Revenue 2013
17.2.6 Business Strategy
17.2.7 Recent Developments
17.2.8 SWOT Analysis
17.3 Bayer HealthCare
17.3.1 Key Facts
17.3.2 Business Overview
17.3.3 Business Segmentation by Revenue 2013
17.3.4 Business Segmentation by Revenue 2012 and 2013
17.3.5 Geographical Segmentation by Revenue 2013
17.3.6 Business Strategy
17.3.7 Recent Developments
17.3.8 SWOT Analysis
17.4 Danaher
17.4.1 Key Facts
17.4.2 Business Overview
17.4.3 Business Segmentation
17.4.4 Revenue by Business Segmentation
17.4.5 Revenue Comparison 2012 and 2013
17.4.6 Segmentation by Geography
17.4.7 Business Strategy
17.4.8 Key Information
17.4.9 SWOT Analysis
17.5 F. Hoffmann-La Roche
17.5.1 Key Facts
17.5.2 Business Overview
17.5.3 Business Segmentation
17.5.4 Geographical Segmentation by Revenue 2013
17.5.5 Business Strategy
17.5.6 Key Information
17.5.7 SWOT Analysis
17.6 Johnson & Johnson
17.6.1 Key Facts
17.6.2 Business Overview
17.6.3 Business Segmentation by Revenue 2013
17.6.4 Business Segmentation by Revenue 2012 and 2013
17.6.5 Geographical Segmentation by Revenue 2013
17.6.6 Business Strategy
17.6.7 Recent Developments
17.6.8 SWOT Analysis
18. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global POC Diagnostics Market 2014-2019 (US$ million)
Exhibit 3: POC Diagnostics Market in US 2014-2019 (US$ million)
Exhibit 4: POC Diagnostics Market in Europe 2014-2019 (US$ million)
Exhibit 5: Segmentation of Global POC Diagnostics Market by Application
Exhibit 6: Global POC Diagnostics Market by Application 2014
Exhibit 7: Global Blood Glucose Testing Market 2014-2019 (US$ million)
Exhibit 8: Global Infectious Diseases Testing Market 2014-2019 (US$ million)
Exhibit 9: Global Cardiac Markers Testing Market 2014-2019 (US$ million)
Exhibit 10: Global Coagulation Testing Market 2014-2019 (US$ million)
Exhibit 11: Global Pregnancy and Fertility Testing Market 2014-2019 (US$ million)
Exhibit 12: Global Blood Gas/Electrolytes Testing Market 2014-2019 (US$ million)
Exhibit 13: Global Tumor Markers Testing Market 2014-2019 (US$ million)
Exhibit 14: Global Urinalysis Testing Market 2014-2019 (US$ million)
Exhibit 15: Global Cholesterol Testing Market 2014-2019 (US$ million)
Exhibit 16: Segmentation of Global POC Diagnostics Market by Application 2014-2019 (US$ million)
Exhibit 17: Segmentation of Global POC Diagnostics Market by Application 2014-2019
Exhibit 18: Geographical Segmentation of Global POC Diagnostics Market 2014
Exhibit 19: POC Diagnostics Market in Americas 2014-2019 (US$ million)
Exhibit 20: POC Diagnostics Market in EMEA Region 2014-2019 (US$ million)
Exhibit 21: POC Diagnostics Market in APAC Region 2014-2019 (US$ million)
Exhibit 22: Geographical Segmentation of Global POC Diagnostics Market 2014-2019 (US$ million)
Exhibit 23: Geographical Segmentation of Global POC Diagnostics Market 2014-2019
Exhibit 24: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 25: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 26: Abbott Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 27: Global POC Diagnostics Market: Business Segmentation by Revenue 2013
Exhibit 28: Global POC Diagnostics Market: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 29: Global POC Diagnostics Market: Geographical Segmentation by Revenue 2013
Exhibit 30: Bayer HealthCare: Business Segmentation by Revenue 2013
Exhibit 31: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 32: Bayer HealthCare: Geographical Segmentation by Revenue 2013
Exhibit 33: Danaher: Business Segmentation
Exhibit 34: Danaher: Business Segmentation 2013
Exhibit 35: Danaher: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 36: Danaher: Revenue by Geographical Segmentation 2013
Exhibit 37: F. Hoffmann-La Roche: Business Segmentation 2013
Exhibit 38: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 39: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals)
Exhibit 40: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics)
Exhibit 41: Johnson & Johnson: Business Segmentation by Revenue 2013
Exhibit 42: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 43: Johnson & Johnson: Geographical Segmentation by Revenue 2013